World Games

Pharming Group reports fourth quarter and full year 2023 financial results

Retrieved on: 
Donnerstag, März 14, 2024
Patient, Health care, Epidemiology, Executive Committee, Laboratory, Microsoft Access, Lymphocyte, Clinical trial, European Commission, APDS, MHLW, AEG, Welfare, Ageing, Committee, EMA, Trial of the century, PID, CTLA4, Safety, Pharmacokinetics, Ministry, CHMP, ODD, U.S. FDA, Prevalence, PTEN, Disease, HAE, Immunodeficiency, VUS, Literature, PIK3R1, PMDA, FDA, DSM-IV codes, Diagnosis, Civil service commission, IRP, Haploinsufficiency, Genetic testing, MAA, Autoimmunity, World Games, Iberian languages, Marketing, MHRA, Euronext Amsterdam, PIK3CD, Physician, Pharmaceutical industry

The U.S. market contributed 97% of 2023 revenues, while the EU and Rest of World contributed 3%.

Key Points: 
  • The U.S. market contributed 97% of 2023 revenues, while the EU and Rest of World contributed 3%.
  • Revenues increased to US$7.9 million in the fourth quarter of 2023, driven by the continued increase in patients on paid therapy, and revenues were US$18.2 million for 2023.
  • Pharming made continued progress in the fourth quarter of 2023 on leniolisib regulatory filings for APDS patients 12 years of age and older in key global markets.
  • Pharming filed regulatory submissions in Canada and Australia in the third quarter of 2023, and Israel in the second quarter.

Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends and Opportunities in Targeted Therapies

Retrieved on: 
Mittwoch, März 13, 2024
Diagnosis, Checkmate, Prevalence, Patient, World Games, SWOT, Biomarker, Research, NCCN, Cancer, EMA, Contract research organization, National Comprehensive Cancer Network, Protein, Medicine, Clinical trial, Drug development, Therapy, Precision, FDA, Pharmaceutical industry

Precision oncology, or personalized medicine, involves the use of biomarker testing to identify the driver mutations of a patient’s cancer and actionable biomarkers for targeted therapy treatment.

Key Points: 
  • Precision oncology, or personalized medicine, involves the use of biomarker testing to identify the driver mutations of a patient’s cancer and actionable biomarkers for targeted therapy treatment.
  • The Precision Oncology - Global Clinical Trial Landscape whitepaper is designed for researchers, clinicians, pharmaceutical, biopharma and biotech firms.
  • It presents a thorough analysis of healthcare, technology, macroeconomic, regulatory trends, SWOT analysis, funding, and innovative research developments in precision oncology.
  • The report provides a detailed review of the current precision oncology landscape including standout trials, important trends around FDA approvals, funding initiatives, and ongoing insights impacting research and development.

Impact Podcast with John Shegerian to Present Special Three-Part Series Featuring In-Depth Interview with Jeanette Lee

Retrieved on: 
Donnerstag, April 4, 2024
Women, Sports, Publishing, Entertainment, Communications, Books, Lifestyle, Consumer, Billiards, Podcast, ESPN, Entrepreneurship, Doc, Black widow, Amazon Music, Gold, Doc NYC, Female, Black, Google Podcasts, WPBA Tour, Memoir, Nature, Life, ERI, Amazon (company), World Games

Champion professional pool player Jeanette Lee , is the subject of a special three-part, in-depth conversation this weekend on the Impact Podcast with John Shegerian .

Key Points: 
  • Champion professional pool player Jeanette Lee , is the subject of a special three-part, in-depth conversation this weekend on the Impact Podcast with John Shegerian .
  • An icon of her sport, Lee was born to Korean-immigrant parents in Brooklyn in 1971.
  • A documentary about her life, Jeanette Lee Vs., premiered at the Doc NYC film festival and is part of the ESPN series 30 for 30.
  • In the Impact Podcast interview, Lee shares details of her rise to fame and how she conquered a unique combination of challenges to get to where she is today.

2026 Special Olympics USA Games Calls New Champions to its Board of Directors

Retrieved on: 
Donnerstag, März 21, 2024
People with Disabilities, Olympics, Sports, Professional Services, Philanthropy, DEI (Diversity, Equity and Inclusion), Fund Raising, Consumer, Foundation, Other Philanthropy, Well, Baseball, Second Continental Congress, Congress, Sport, University of Minnesota, First lady, Special Olympics USA, Special Olympics World Games, Prison, Chairperson, Special, Strategic planning, CBO, University, Sunshine Studios, Meka, Chicago Bears, Life, Athlete, Minnesota Twins, Special Olympics, New York Yankees, Olympic Games, LGBTQ, Love, Disability, Movement, Chicago White Sox, World Games, Major League Baseball, Teaching, Management

Special Olympics today appointed seven new leaders to the organization's 2026 Special Olympics USA Games Board of Directors to help oversee the national celebration of inclusivity that will bring together thousands from all 50 states to Minnesota.

Key Points: 
  • Special Olympics today appointed seven new leaders to the organization's 2026 Special Olympics USA Games Board of Directors to help oversee the national celebration of inclusivity that will bring together thousands from all 50 states to Minnesota.
  • “We are thrilled to add seven new members to our existing board of directors who are dedicated to leading the 2026 USA Games with the same joy, excitement and inclusivity our athletes demonstrate each time they compete,” said Adam Hjerpe, Board Chair, 2026 Special Olympics USA Games.
  • I look forward to helping the 2026 Special Olympics USA Games Board of Directors ensure the 2026 USA Games leaves a lasting and memorable legacy within our community and beyond.”
    The seven new members appointed to the 2026 Special Olympics USA Games Board of Directors are:
    Gwen Walz: Gwen is the First Lady of Minnesota, a former English teacher and lifelong Minnesotan.
  • These leaders join the existing board members of the 2026 Special Olympics USA Games, including Adam Hjerpe, board chair; Christy Sovereign, CEO, 2026 Special Olympics USA Games; Terry Clark, co-presenting partner, United Healthcare; Caroline Jones, co-presenting partner, Jersey Mike’s Subs; Dave Dorn, president, Special Olympics Minnesota; Wendy Blackshaw, CEO, Minnesota Sports and Events; Jon Steadland, chief of staff, office of the president, University of Minnesota; David Booth, athlete representative, Special Olympics Minnesota; and Will Smith, athlete representative, Special Olympics of New York.

Global Classic Car Insurance Market Report 2024 with Analyst Recommendations: Focus on Streamlining the Operations and Enhance Customer Experience through Online Platforms - ResearchAndMarkets.com

Retrieved on: 
Dienstag, März 12, 2024
Professional Services, Insurance, Performance & Special Interest, Automotive, Online, Theft, Channel, Growth, Porter's five forces analysis, Risk, World Games, SWOT, Investment, USD

The Global Classic Car Insurance market showcased growth at a CAGR of 7.11% during 2019-2022.

Key Points: 
  • The Global Classic Car Insurance market showcased growth at a CAGR of 7.11% during 2019-2022.
  • The report analyses the Classic Car Insurance Market by Region (North America, Europe, and Rest of World) and 6 Countries (United States, Canada, Germany, United Kingdom, France, and Italy).
  • The report analyses the Classic Car Insurance Market By Vehicle Type (Vintage, and Classic).
  • The report analyses the Classic Car Insurance Market By Channel (Direct Sales, Agents/Brokers, and Online Platforms).

Wolters Kluwer 2023 Full-Year Report

Retrieved on: 
Mittwoch, Februar 21, 2024
Software, Depreciation, Artificial intelligence, Investment, Targets, Growth, Annual report, DRIP, Divestment, Share repurchase, Tax, Marketing, ABN, Data collection, Overalls, Disclosure, Treasury, World Games, Science Based Targets initiative, Income tax, EPS, Microsoft, Total, Dividend, Digital, ESG, Risk, Capital expenditure, Public expenditure, Science, GHG, Acquisition, Wolters Kluwer, AMRO Bank, Thumb, Policy, Full-time equivalent, Annual, FTE, Travel, Pharmaceutical industry

In 2023, Wolters Kluwer generated over 60% of its revenues and adjusted operating profit in North America.

Key Points: 
  • In 2023, Wolters Kluwer generated over 60% of its revenues and adjusted operating profit in North America.
  • Legal Regulatory: we expect full-year 2024 organic growth to be in line with prior year (FY 2023: 4%).
  • Wolters Kluwer uses its free cash flow to invest in the business organically and through acquisitions, to maintain optimal leverage, and to provide returns to shareholders.
  • Wolters Kluwer remains committed to a progressive dividend policy, under which we aim to increase the dividend per share in euros each year, independent of currency fluctuations.

Dole plc Announces Sale of Progressive Produce to Arable Capital

Retrieved on: 
Dienstag, Februar 27, 2024
Retail, Restaurant, Bar, Supermarket, Agriculture, Natural Resources, Food, Beverage, Arable, DOLE, Fruit, Investment, Growth, Sale, Dole plc, World Games, K&L Gates, LLP, Montminy, Cryptocurrency

Dole plc (NYSE: DOLE) (“Dole” or the “Group”) has today announced that it has reached an agreement to sell its 65% equity stake in Progressive Produce LLC (“Progressive Produce” or the “Company”) to PTF Holdings, LLC (“PTF Holdings”), the parent company of Pacific Trellis Fruit, LLC (“Pacific Trellis Fruit”).

Key Points: 
  • Dole plc (NYSE: DOLE) (“Dole” or the “Group”) has today announced that it has reached an agreement to sell its 65% equity stake in Progressive Produce LLC (“Progressive Produce” or the “Company”) to PTF Holdings, LLC (“PTF Holdings”), the parent company of Pacific Trellis Fruit, LLC (“Pacific Trellis Fruit”).
  • Progressive Produce is a subsidiary of Dole plc and is part of the Diversified Fresh Produce – Americas and Rest of World reporting segment.
  • Post the completion of this transaction, the existing management team of Progressive Produce will remain with the enlarged business of Progressive Produce and Pacific Trellis Fruit and retain an ownership stake.
  • Commenting on the transaction, Carl McCann, Executive Chairman of Dole plc, said:
    “We are pleased to announce the sale of our equity interest in Progressive Produce to Arable Capital Partners.

Clinical Chemistry Analyzers Market, Size, Global Forecast Report 2024-2030 Featuring Thermo Fisher Scientific, Abbott Laboratories, Siemens, Danaher, Johnson & Johnson, Sysmex ADR, HORIBA, Hitachi - ResearchAndMarkets.com

Retrieved on: 
Montag, Februar 26, 2024
Science, Health, Research, Other Health, Diabetes, Incidence, Sickness, BMP, Intelligence, IDF, Immunochemistry, Calcium, World Games, Gynaecology, Electrolyte, Endocrinology, Biomarker, Disease, Glucose, Diagnosis, Basic metabolic panel, WHO, DSM-IV codes, Cancer, Medical device

The "Clinical Chemistry Analyzers Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Chemistry Analyzers Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Technological improvements in clinical chemistry analyzers have enabled broader testing skills and early sickness detection, particularly in specialized sectors like cancer, gynecology, and endocrinology.
  • These essential chemical substances enable clinical chemistry analyzers to detect and measure various biomarkers, making them indispensable in the healthcare industry.
  • U.S.-based manufacturers continually introduce state-of-the-art clinical chemistry analyzers that cater to the evolving requirements of healthcare providers.

EClinical Solutions Market size to grow by USD 9.7 billion from 2022 to 2027, North America to account for 41% of market growth, Technavio

Retrieved on: 
Mittwoch, März 6, 2024
Research, Biotechnology, USD, Artificial intelligence, Clinical data management, Investment, CTMS, Data management, Growth, Drug development, Geography, World Games, ChromeOS, Data analysis, Clinical trial, Cloud computing, Machine learning, Workforce, ROW, Pharmaceutical industry

NEW YORK, March 6, 2024 /PRNewswire/ -- The eclinical solutions market is expected to grow by USD 9.7 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, March 6, 2024 /PRNewswire/ -- The eclinical solutions market is expected to grow by USD 9.7 billion from 2022 to 2027.
  • In addition, the momentum of the market will progress at a CAGR of  13.47% during the forecast period, according to Technavio Research.
  • This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment.
  • The global rehabilitation equipment market size is estimated to grow by USD 3.67 billion at a CAGR of 4.44% between 2023 and 2028.

The Global Market for Conductive Plastics 2024-2034, with Profiles of 60 Companies Including Avient, BASF, Birla Carbon, Cabot, Imerys, KH Chemicals, LG Chem, Mitsubishi Chemical, N-ink, OCSiAl & PCBL - ResearchAndMarkets.com

Retrieved on: 
Montag, Februar 12, 2024
Chemicals, Plastics, Manufacturing, Flexible, Polyaniline, Medicine, Polychlorinated biphenyl, Electricity, Investment, Carbon, World Games, ICPS, Sensor, Antistatic agent, Metal, Electrical conductor, Interiors, Renewable energy, Plastic, Market, EMI, Printed circuit board

Generally, plastics are not good conductors of electricity as they consist of non-conductive molecules.

Key Points: 
  • Generally, plastics are not good conductors of electricity as they consist of non-conductive molecules.
  • However, with the addition of conductive fillers or additives, some plastics can develop electrically conductive properties.
  • Examples of conductive plastics include polyaniline, polypyrrole, polythiophene, and some carbon nanomaterials like graphene and carbon nanotubes.
  • The Global Market for Conductive Plastics 2024-2034 provides a comprehensive analysis of the global conductive plastics market, including market size valuations and growth projections.